Michael J. Fox made an appearance over the weekend at the Fan Expo in New Orleans, alongside his cast members from the Back ...

While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

It can improve motor symptoms, including tremors. Deep brain stimulation (DBS) will continue to see high usage in Parkinson’s ...

The Aligning Science Across Parkinson’s (ASAP) initiative opened applications for members of the research community to apply to join the Collaborative Research Network (CRN) 2025 Scientific Track. The ...

Neurological conditions are now the leading cause of ill health worldwide, yet remain an enigma. Meet the patients who baffle ...

On “Poet of Motel 6,” due March 21, the country musician known for shocking audiences grapples with death and his own legacy.

Acadia files regulatory application for trofinetide to treat Rett syndrome in EU. The company also outlines other pipeline goals for 2025-2026.

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...